Effects of Gadobutrol on background parenchymal enhancement in breast dynamic MRI
Not Applicable
- Conditions
- Patients who are scheduled to undergo breast dynamic MRI for breast cancer or suspected breast cancer
- Registration Number
- JPRN-UMIN000026386
- Lead Sponsor
- Sagara hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
-Patients with known hypersensitivity to gadolinium-based contrast agents -Patients with renal impairment (e-GFR : less than 30mL/min/1.73m2) -Pregnant, Parturient or breastfeeding women -Patients who experienced breast cancer in the past, with invasive treatment -Patients receiving drug therapy for breast cancer -Patients who are inappropriate for enrolment for any other reason in the opinion of the investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the effect of background parenchymal enhancement on contrast during the early phase of breast dynamic MRI using background : lesion-to-background contrast with gadobutrol will be compared with the large-scale data
- Secondary Outcome Measures
Name Time Method To characterize the TIC of gadobutrol-enhanced breast dynamic MRI : The TIC will be compared with previous reports and discussed